DNTH Stock Price
DNTH
$83.01
-$2.80(-3.26%)
55
Overall
60
Value
63
Tech
44
Quality
Market Cap
$4.80B
Volume
1.06M
52W Range
-- - --
Target Price
$138.53
DNTH stock price is $83.01 (-3.26% on the day), giving DNTH a market cap of $4.80B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
DNTH Stock Overview
- Price
- $83.01
- Previous close
- $85.81
- Open
- $85.87
- Market cap
- $4.80B
- 1-year price target
- $138.53
- MarketXLS Rank
- 55
About DNTH
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. The company is developing DNTH103, a monoclonal antibody, which is in clinical-stage trial, for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNTH | $83.01 | -3.3% | 1.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |